Bain Capital Specialty Finance, Inc.
Bain Capital Specialty Finance, Inc. (BCSF) Financial Performance & Income Statement Overview
Explore the financials of Bain Capital Specialty Finance, Inc. (BCSF), including yearly and quarterly data on income, cash flow, and balance sheets.
Bain Capital Specialty Finance, Inc. (BCSF) Income Statement & Financial Overview
Analyze Bain Capital Specialty Finance, Inc.’s BCSF earnings with segmented quarterly and yearly financial statement figures.
| Metric | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 |
|---|---|---|---|---|
| Revenue | $52.84M | $27.11M | $37.62M | $54.43M |
| Cost of Revenue | $0.00 | $0.00 | $0.00 | $20.51M |
| Gross Profit | $52.84M | $27.11M | $37.62M | $33.92M |
| Gross Profit Ratio | $1.00 | $1.00 | $1.00 | $0.62 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $3.29M | $3.70M | $3.32M | $3.68M |
| Operating Expenses | $3.29M | $3.70M | $3.32M | $3.51M |
| Total Costs & Expenses | $3.29M | $3.70M | $3.50M | $3.68M |
| Interest Income | $0.00 | $56.12M | $55.42M | $55.11M |
| Interest Expense | $18.90M | $20.88M | $18.12M | $17.63M |
| Depreciation & Amortization | $0.00 | $0.00 | $533000.00 | -$51.90M |
| EBITDA | $0.00 | $0.00 | $51.70M | $0.00 |
| EBITDA Ratio | $0.00 | $0.00 | $1.37 | $0.00 |
| Operating Income | $49.55M | $23.41M | $34.12M | $51.90M |
| Operating Income Ratio | $0.94 | $0.86 | $0.91 | $0.95 |
| Other Income/Expenses (Net) | -$16.36M | $0.00 | $0.00 | -$21.66M |
| Income Before Tax | $33.19M | $23.41M | $34.12M | $30.24M |
| Income Before Tax Ratio | $0.63 | $0.86 | $0.91 | $0.56 |
| Income Tax Expense | $1.08M | $1.27M | $1.02M | $1.15M |
| Net Income | $32.11M | $22.14M | $33.10M | $29.09M |
| Net Income Ratio | $0.61 | $0.82 | $0.88 | $0.53 |
| EPS | $0.50 | $0.34 | $0.51 | $0.45 |
| Diluted EPS | $0.50 | $0.34 | $0.51 | $0.45 |
| Weighted Avg Shares Outstanding | $64.68M | $64.56M | $64.56M | $64.56M |
| Weighted Avg Shares Outstanding (Diluted) | $64.68M | $64.56M | $64.56M | $64.56M |
The company's financials show resilient growth, with revenue advancing from $54.43M in Q2 2024 to $52.84M in Q1 2025. Gross profit remained healthy with margins at 100% in Q1 2025 compared to 62% in Q2 2024. Operating income hit $49.55M last quarter, sustaining a consistent 94% margin. Changes in R&D and SG&A spending did not hinder EBITDA, which stood at $0.00. Net income rose to $32.11M, while earnings per share reached $0.50. Strong cost management and operational efficiency kept profitability intact, underlining the company's stable and competitive market performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan